Tag: Cancer: Esophageal
Fruquintinib + Paclitaxel Aids Advanced Gastric/Gastroesophageal Junction Cancer
Improvement seen in progression-free survival among patients who had disease progression on first-line chemotherapy
Consumption of Ultra-Processed Foods Tied to Upper Digestive Tract Cancers
Increased body fat only explained a small proportion of the association
ESMO: Pembrolizumab + Chemo, Trastuzumab Beneficial in Gastroesophageal Cancer
Improvement seen in progression-free survival with add-on pembrolizumab in gastroesophageal junction adenocarcinoma
Zolbetuximab Plus CAPOX Beneficial for Advanced mG/GEJ Adenocarcinoma
Progression-free survival and overall survival prolonged with zolbetuximab plus CAPOX versus placebo plus CAPOX
K-ECAN Tool Can Predict Esophageal, Gastric Cardia Adenocarcinoma
Screening tool was well calibrated and had better discrimination than previous models including HUNT, Kunzmann
One-Fourth of Esophageal Cancers Among Those With BE Missed in Year Before Diagnosis
Authors say there is need to improve effectiveness of screening and surveillance practices for early cancer detection in patients with Barrett esophagus
Overweight, Obesity in Early, Middle Adulthood Increases Risk for GI Cancers
Risk not reduced with aspirin use three or more times per week for colorectal and noncolorectal cancers
Survival Similar for Early, Delayed Surgery in Stage I Esophageal Cancer
For patients with stage II/III esophageal cancer, five-year survival is improved with early versus delayed esophagectomy
DDW: ‘Alarming’ Rise in Esophageal Cancer, Barrett Esophagus Seen in Middle-Age
Number of endoscopies performed not increasing, despite increased prevalence
Guidelines Updated for Barrett Esophagus Diagnosis, Management
Guideline revised to synthesize current best practices in the management of Barrett esophagus
